0001079973-24-000085.txt : 20240119 0001079973-24-000085.hdr.sgml : 20240119 20240119110121 ACCESSION NUMBER: 0001079973-24-000085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240117 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schornstein Alexander CENTRAL INDEX KEY: 0001999256 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35005 FILM NUMBER: 24544268 MAIL ADDRESS: STREET 1: KAISER-FRIEDRICH-ALLEE 2 CITY: AACHEN STATE: 2M ZIP: 52074 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001426800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO TOWER PLACE STREET 2: 7TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (833) 409-4583 MAIL ADDRESS: STREET 1: TWO TOWER PLACE STREET 2: 7TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC DATE OF NAME CHANGE: 20080211 4 1 ownership.xml X0508 4 2024-01-17 0 0001426800 ASSEMBLY BIOSCIENCES, INC. ASMB 0001999256 Schornstein Alexander KAISER-FRIEDRICH-ALLEE 2 AACHEN 2M 52074 GERMANY 0 0 1 0 0 Common Stock 2024-01-17 4 P 0 299994 0.784 A 7864286 D Common Stock 2024-01-18 4 P 0 345086 0.80 A 8209372 D The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds. The price reported is the midpoint of the price range at which the shares were purchased. 299,994 shares were purchased on January 17, 2024, in multiple transactions at prices ranging from $0.768 to $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. 345,086 shares were purchased on January 18, 2024, in multiple transactions at $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. /s/ Alexander Schornstein 2024-01-19